Abstract
Background
Effects of chronic cadmium exposure on liver disease and liver-related mortality are unknown. We evaluated the association of creatinine-corrected urinary cadmium levels with hepatic necroinflammation, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver-related mortality, and liver cancer mortality in the US general population.
Methods
We analyzed the relationship of individuals in the top quartile for urinary cadmium measured in 12,732 adults who participated in the Third National Health and Nutrition Examination Survey in 1988–1994 (NHANES III), and hepatic necroinflammation, NAFLD, and NASH. Associations between cadmium, liver-related mortality, and liver cancer mortality were evaluated in the NHANES III mortality follow-up study.
Results
The cutoffs for highest quartile of urinary cadmium per gram of urinary creatinine were 0.65 and 0.83 μg/g for men and women, respectively (P < 0.001). After multivariate adjustment for other factors including smoking, the odds ratios [95 % confidence intervals (CI)] for hepatic necroinflammation, NAFLD, and NASH associated with being in the top quartile of cadmium levels by gender, were 2.21 (95 % CI, 1.64–3.00), 1.30 (95 % CI, 1.01–1.68) and 1.95 (95 % CI, 1.11–3.41) for men and 1.26 (95 % CI, 1.01–1.57), 1.11 (95 % CI, 0.88–1.41) and 1.34 (95 % CI, 0.72–2.50) for women, respectively. The hazard ratios for liver-related mortality and liver cancer mortality for both genders were 3.42 (95 % CI, 1.12–10.47) and 1.25 (95 % CI, 0.37–4.27).
Conclusions
Environmental cadmium exposure was associated with hepatic necroinflammation, NAFLD, and NASH in men, and hepatic necroinflammation in women. Individuals in the top quartile of creatinine-corrected urinary cadmium had over a threefold increased risk of liver disease mortality but not in liver cancer related mortality.
Similar content being viewed by others
Abbreviations
- NAFLD:
-
Non-alcoholic fatty liver disease
- NASH:
-
Non-alcoholic steatohepatitis
- NHANES:
-
National Health and Nutrition Examination Survey
- CI:
-
Confidence intervals
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- BMI:
-
Body mass index
- GGT:
-
γ-Glutamyltranspeptidase
- OR:
-
Odds ratio
- HR:
-
Hazard ratio
- MT:
-
Metallothionein
References
Satarug S, Moore MR. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environmental health perspectives 2004;112(10):1099–103.
Verougstraete V, Lison D, Hotz P. Cadmium, lung and prostate cancer: a systematic review of recent epidemiological data. Journal of toxicology and environmental health. Part B, Critical reviews 2003;6(3):227–55.
Bernard A. Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals: an international journal on the role of metal ions in biology, biochemistry, and medicine 2004;17(5):519–23.
Menke A, Munter P, Silbergeld EK, Platz EA, Guallar E. Cadmium levels in urine and mortality among U.S. adults. Environmental health perspectives 2009;117(2):190–96.
Habeebu SS, Liu J, Liu YP, Klaassen CD. Metallothionein-null mice are more sensitive than wild-type mice to liver injury induced by repeated exposure to cadmium. Toxicol Sci 2000;55(1):223–32.
Statistics NCfH. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–1994. In: Service DoHaH, editor, 1994
Ioannou GN, Morrow OB, Connole ML, Lee SP. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 2009;50(1):175–84.
Paschal DC, Burt V, Caudill SP, Gunter EW, Pirkle JL, Sampson EJ, et al. Exposure of the U.S. population aged 6 years and older to cadmium: 1988–1994. Archives of environmental contamination and toxicology 2000;38(3):377–83.
Statistics NCfH. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988–1994: Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Environmental Health, 1996.
Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood-donors. New Engl J Med 1988;318(21):1355–62.
Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718–24.
Afzali A, Weiss NS, Boyko EJ, Ioannou GN. Association between serum uric acid level and chronic liver disease in the United States. Hepatology 2010;52(2):578–89.
Statistics NCfH. Hepatic steatosis assessment procedure manual, 2010.
Westat. Third National Health and Nutritional Survey: gallbladder ultrasonography procedure manual, 1988.
Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. Brit Med J 2011;343.
Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Sharrett AR, Guallar E. Cadmium and peripheral arterial disease: gender differences in the 1999–2004 US National Health and Nutrition Examination Survey. American journal of epidemiology 2010;172(6):671–81.
Ferraro PM, Costanzi S, Naticchia A, Sturniolo A, Gambaro G. Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999–2006. BMC public health 2010;10:304.
Schwartz GG, Il’yasova D, Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care 2003;26(2):468–70.
Nordberg GF, Piscator M, Nordberg M. On the distribution of cadmium in blood. Acta Pharmacol Toxicol 1971;30:289–95.
Agarwal S, Zaman T, Tuzcu EM, Kapadia SR. Heavy metals and cardiovascular disease: results from the National Health and Nutrition Examination Survey (NHANES) 1999–2006. Angiology 2011;62(5):422–9.
Jarup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 2009;238(3):201–8.
Nash D, Magder LS, Sherwin R, Rubin RJ, Silbergeld EK. Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994. American journal of epidemiology 2004;160(9):901–11.
Vahter M, Akesson A, Liden C, Ceccatelli S, Berglund M. Gender differences in the disposition and toxicity of metals. Environ Res 2007;104(1):85–95.
Andujar P, Bensefa-Colas L, Descatha A. Acute and chronic cadmium poisoning. Rev Med Interne 2010;31(2):107–15.
Adams SV, Passarelli MN, Newcomb PA. Cadmium exposure and cancer mortality in the Third National Health and Nutrition Examination Survey cohort. Occupational and environmental medicine 2012;69(2):153–6.
Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011;54(3):1082–90.
Conflict of Interest
The authors declare no conflict of interest.
Financial Support
No financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hyder, O., Chung, M., Cosgrove, D. et al. Cadmium Exposure and Liver Disease among US Adults. J Gastrointest Surg 17, 1265–1273 (2013). https://doi.org/10.1007/s11605-013-2210-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-013-2210-9